Intellia Therapeutics (NTLA) - positive Forschungsdaten bringen die Aktie auf ein neues Jahreshoch und entfachen die Wachstumsfantasie entlang des gesamten CRISPR-Sektors!
array (
1275 =>
array (
'term_id' => '1275',
'name' => 'US75886F1075',
'slug' => 'us75886f1075',
'term_group' => '0',
'count' => '21',
'taxonomy_id' => '1275',
'stock_name' => 'Regeneron Pharmaceuticals Inc.',
'stock' =>
array (
'id' => '67482',
'wkn' => '881535',
'isin' => 'US75886F1075',
'symbol' => 'REGN',
'name' => 'Regeneron Pharmaceuticals Inc.',
'source' => 'DI',
'type' => 'Aktie',
'fn_type' => 'Share',
'digits' => '3',
'prefix' => '',
'postfix' => ' $',
'home' => 'US',
'currency' => 'USD',
'factset_country' => 'US',
'open_time' => '15:30',
'close_time' => '22:00',
'active' => 'Y',
'main_indication_id' => '67482',
'v' => 895.94916,
'p' => 0.27,
't' => 1713556793,
),
),
1320 =>
array (
'term_id' => '1320',
'name' => 'CH0334081137',
'slug' => 'ch0334081137',
'term_group' => '0',
'count' => '8',
'taxonomy_id' => '1320',
'stock_name' => 'CRISPR Therapeutics AG',
'stock' =>
array (
'id' => '3199611',
'wkn' => 'A2AT0Z',
'isin' => 'CH0334081137',
'symbol' => 'CRSP',
'name' => 'CRISPR Therapeutics AG',
'source' => 'DI',
'type' => 'Aktie',
'fn_type' => NULL,
'digits' => '3',
'prefix' => '',
'postfix' => ' $',
'home' => 'CH',
'currency' => 'USD',
'factset_country' => 'CH',
'open_time' => '15:30',
'close_time' => '22:00',
'active' => 'Y',
'main_indication_id' => NULL,
'v' => NULL,
'p' => NULL,
't' => NULL,
),
),
1983 =>
array (
'term_id' => '1983',
'name' => 'US28106W1036',
'slug' => 'us28106w1036',
'term_group' => '0',
'count' => '8',
'taxonomy_id' => '1983',
'stock_name' => 'Editas Medicine Inc.',
'stock' =>
array (
'id' => '2904338',
'wkn' => 'A2AC4K',
'isin' => 'US28106W1036',
'symbol' => 'EDIT',
'name' => 'Editas Medicine Inc.',
'source' => 'DI',
'type' => 'Aktie',
'fn_type' => NULL,
'digits' => '3',
'prefix' => '',
'postfix' => ' $',
'home' => 'US',
'currency' => 'USD',
'factset_country' => 'US',
'open_time' => '15:30',
'close_time' => '22:00',
'active' => 'Y',
'main_indication_id' => '2904338',
'v' => 5.47507,
'p' => -1.35,
't' => 1713556722,
),
),
2522 =>
array (
'term_id' => '2522',
'name' => 'US45826J1051',
'slug' => 'us45826j1051',
'term_group' => '0',
'count' => '6',
'taxonomy_id' => '2522',
'stock_name' => 'Intellia Therapeutics Inc.',
'stock' =>
array (
'id' => '6200197',
'wkn' => 'A2AG6H',
'isin' => 'US45826J1051',
'symbol' => 'NTLA',
'name' => 'Intellia Therapeutics Inc.',
'source' => 'DI',
'type' => 'Aktie',
'fn_type' => NULL,
'digits' => '3',
'prefix' => '',
'postfix' => ' $',
'home' => 'US',
'currency' => 'USD',
'factset_country' => 'US',
'open_time' => '15:30',
'close_time' => '22:00',
'active' => 'Y',
'main_indication_id' => '6200197',
'v' => 21.5569,
'p' => 1.11,
't' => 1713556787,
),
),
3978 =>
array (
'term_id' => '3978',
'name' => 'US8006771062',
'slug' => 'us8006771062',
'term_group' => '0',
'count' => '1',
'taxonomy_id' => '3978',
'stock_name' => 'Sangamo Biosciences',
'stock' =>
array (
'id' => '67768',
'wkn' => '936386',
'isin' => 'US8006771062',
'symbol' => 'SGMO',
'name' => 'Sangamo Biosciences',
'source' => 'DI',
'type' => 'Aktie',
'fn_type' => 'Share',
'digits' => '3',
'prefix' => '',
'postfix' => ' $',
'home' => 'US',
'currency' => 'USD',
'factset_country' => 'US',
'open_time' => '15:30',
'close_time' => '22:00',
'active' => 'Y',
'main_indication_id' => '67768',
'v' => 0.51145,
'p' => 5.39,
't' => 1713556799,
),
),
)
Als Abonnent unseres aktien Magazins haben sie Zugriff auf diesen Premium-Artikel. Loggen Sie sich einfach ein, um diesen Artikel lesen zu können.
Wie wird die Welt in 10 Jahren aussehen? Welche Technologien und Organisationsfirmen werden sich durchsetzen? Rund um Anlage- und Zukunfstrends haben wir ein eigenes Aktien-Research aufgebaut.
